Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,187 | -225,821 | -155,264 | -91,673 | -29,627 |
| Depreciation Amortization | 1,754 | 3,154 | 1,121 | 332 | 206 |
| Accounts receivable | -5,672 | 816 | 4,777 | 2,118 | 5,413 |
| Accounts payable and accrued liabilities | -4,673 | 8,444 | 300 | 325 | 197 |
| Other Working Capital | -17,744 | -29,030 | -20,460 | -11,252 | 6,274 |
| Other Operating Activity | 77,740 | 39,549 | 35,360 | 28,838 | 774 |
| Operating Cash Flow | $78,592 | $-202,888 | $-134,166 | $-71,312 | $-16,763 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 45,831 | 71,664 | 33,489 | 72,539 | 26,541 |
| PPE Investments | -1,031 | -1,119 | -116 | -5 | N/A |
| Investing Cash Flow | $44,800 | $70,545 | $33,373 | $72,534 | $26,541 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,588 | 170,623 | 168,789 | 167,379 | 1,724 |
| Other Financing Activity | -13,492 | -7,792 | -7,792 | -7,792 | 0 |
| Financing Cash Flow | $-8,904 | $162,831 | $160,997 | $159,587 | $1,724 |
| Exchange Rate Effect | 85 | -17 | 19 | 48 | 38 |
| Beginning Cash Position | 88,838 | 58,367 | 58,367 | 58,367 | 58,367 |
| End Cash Position | 203,411 | 88,838 | 118,590 | 219,224 | 69,907 |
| Net Cash Flow | $114,573 | $30,471 | $60,223 | $160,857 | $11,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78,592 | -202,888 | -134,166 | -71,312 | -16,763 |
| Capital Expenditure | -1,031 | -1,119 | -116 | -5 | N/A |
| Free Cash Flow | 77,561 | -204,007 | -134,282 | -71,317 | -16,763 |